НовостиBenzingaLeerink Partners Initiates Coverage On Q32 Bio with Outperform Rating, Announces Price Target of $40 Leerink Partners Initiates Coverage On Q32 Bio with Outperform Rating, Announces Price Target of $40 Benzinga 2026.10.12 12:25 (GMT+0) Открыть на Benzinga Другие новости